NIFTYHEALTHCAREINDEX · NSE
Nifty Healthcare
Index · View only — not on the trading terminal
₹17,474.6
+0.78% (+₹135.65)
Prev. close
₹17,338.95
Volume
2,53,50,508
As of
20 Nov 2026
Price history
Analyst sentiment
Analysts lean bullish
4 analyst stances · last 90 days · one per analyst
Trackable
none in range
Long-Horizon
none in range
Commentary
4 · 4 bull / 0 neutral / 0 bear
Trackable = verdict-bearing calls · Long-Horizon = 1yr+ horizon, verdict pending · Commentary = context, not graded
Analyst opinions
| Call | Analyst | Instrument | Verdict | Actions |
|---|---|---|---|---|
| “Recommends an underweight stance on Healthcare, as Morgan Stanley prefers Domestic Cyclicals over Defensives and Externa…” | Ridham DesaiMorgan Stanley | Healthcare | HIT |
Market commentary · 42 · levels, conditionals, previews, macro & hedged views — context, not graded
| Call | Analyst | Instrument | Verdict | Actions |
|---|---|---|---|---|
| “Positive on the healthcare sector, citing robust growth in India branded generics, steady growth for CDMO players due to…” | Shibani Sircar KurianKotak Mahindra AMC | Nifty Healthcare Index | — | |
| “Bullish on the Healthcare sector, linking its gains to encouraging September-quarter earnings and resilient business fun…” | Siddharth PurohitInvestValue | Nifty Healthcare Index | — | |
| “Favors the healthcare sector, particularly hospitals, which continue to benefit from low healthcare penetration and sust…” | Surendra GoyalCiti | Nifty Healthcare Index | — | |
| “PL Capital is overweight on the healthcare sector, indicating a bullish stance due to expected strong performance and gr…” | PL Capital AnalysisPL Capital | Nifty Healthcare Index | — | |
| “Narendra Solanki is constructive on the healthcare sector, particularly hospitals, and anticipates a gradual turnaround …” | Narendra SolankiAnand Rathi Shares & Stock Brokers | Nifty Healthcare Index | — | |
| “Bullish on the healthcare sector, identifying it as a turnaround candidate. After facing pressures from the US market an…” | V SrivatsaUTI AMC | Nifty Healthcare Index | — | |
| “Goldman Sachs has issued a mix of Buy and Neutral calls on key players in the healthcare sector, including KIMS, Max Hea…” | Goldman Sachs AnalysisGoldman Sachs Group Inc. | Nifty Healthcare Index | — | |
| “Bullish on the healthcare sector as a multi-year theme, citing steady organic and inorganic growth, improved profitabili…” | Jayesh SundarAxis Mutual Fund | Nifty Healthcare Index | — | |
| “Bullish on the healthcare theme, driven by initiatives like Ayushman Bharat and the shift towards insurance-led healthca…” | Saurabh MukherjeaMarcellus Investment Managers | Nifty Healthcare Index | — | |
| “Bullish on the Healthcare sector as a long-term structural bet, specifically hospitals, diagnostics, and health insurers…” | Rakshit RanjanMarcellus Investment Managers | Nifty Healthcare Index | — | |
| “Bullish on the healthcare sector as a key structural investment theme for the next decade, emphasizing the importance of…” | Ajay SrivastavaDimensions Corporate Finance | Nifty Healthcare Index | — | |
| “Bullish on the healthcare sector, citing its under-penetration, undervaluation, and steady growth potential, especially …” | Deepak ShenoyCapitalmind Mutual Fund | Nifty Healthcare Index | — | |
| “Bullish on the Healthcare and Hospitals sector, expecting it to maintain strong growth driven by formalization and risin…” | Mahesh PatilAditya Birla Sun Life AMC Ltd | Nifty Healthcare Index | — | |
| “Bullish on the Indian healthcare sector for Q2FY26, forecasting robust revenue growth in the high teens year-on-year, dr…” | Choice Institutional Equities AnalysisChoice Institutional Equities | Nifty Healthcare Index | — | |
| “Bullish on the healthcare sector, expecting improved margins for hospital companies due to recent policy changes allowin…” | Amnish AggarwalPrabhudas Lilladher Capital | Nifty Healthcare Index | — | |
| “Overweight on the Healthcare sector, despite trimming exposure, reflecting its continued importance in their model portf…” | PL Capital AnalysisPL Capital | Nifty Healthcare Index | — | |
| “Positive on the healthcare sector, seeing a long runway for growth as its share in GDP is less than 5% and is expected t…” | Amit PremchandaniUTI Mutual Fund | Healthcare | — | |
| “Bullish on the hospitals sub-sector within healthcare, viewing it as the best investment opportunity due to India's unde…” | Hiren VedAlchemy Capital Management | Nifty Healthcare Index | — | |
| “Bullish on the Healthcare sector, considering it evergreen with strong growth potential for Indian companies due to sign…” | Manish BhandariVallum Capital Advisors | Nifty Healthcare Index | — | |
| “Bullish on specific healthcare segments, preferring R&D-oriented and CDMO players, diagnostics, and hospitals. This stra…” | Mihir VoraTrust MF | Nifty Healthcare Index | — | |
| “Bullish on the healthcare sector, which is holding ground despite selloffs in pharma stocks. Recommends betting on healt…” | Rajesh PalviyaIndependent | Nifty Healthcare Index | — | |
| “Favors the Healthcare sector, specifically hospitals and Contract Development and Manufacturing Organizations (CDMOs), o…” | Ashish GuptaAxis Mutual Fund | Nifty Healthcare Index | — | |
| “Healthcare is expected to be a strong sector with real upside, even with reductions in Medicaid reimbursements. The trav…” | Seth R FreemanGlassRatner Advisory | Healthcare | — | |
| “Bullish on the healthcare segment, particularly hospitals and diagnostics, which are geared towards healthy medium-term …” | Varun GoelMirae Asset Investment Managers | Nifty Healthcare Index | — | |
| “Positive on the healthcare sector from a long-term perspective. The sector is anticipated to benefit from a broader cons…” | Amit PremchandaniUTI Mutual Fund | Nifty Healthcare Index | — | |
| “Marcellus is strategically allocating capital to companies with resilient business models, such as a hospital chain with…” | Rakshit RanjanMarcellus Investment Managers | Nifty Healthcare Index | — | |
| “ASK Investment Managers is bullish on the healthcare ecosystem for FY26, including US generics, domestic pharma, API, CD…” | Sumit JainASK Investment Managers | Nifty Healthcare Index | — | |
| “Bernstein has upgraded the healthcare sector to equal-weight, citing its limited exposure to the adverse effects of the …” | Bernstein AnalysisBernstein | Nifty Healthcare Index | — | |
| “Bullish on the Hospitals & Healthcare sector for FY26, expecting it to benefit from rising medical tourism and increased…” | Anand Rathi AnalysisAnand Rathi | Nifty Healthcare Index | — | |
| “Bearish on the Healthcare sector, as its significant exposure to the US market means that tariffs are dampening foreign …” | U R BhatAlphaniti | Nifty Healthcare Index | — | |
| “Bullish on the Healthcare sector, which is experiencing steady domestic demand, particularly in chronic therapies, drivi…” | Motilal Oswal AnalysisMotilal Oswal Financial Services | Healthcare | — | |
| “Maintains an Overweight stance on the Healthcare sector, citing expected demand recovery and improving macroeconomic tre…” | Emkay Global Financial Services AnalysisEmkay Global Financial Services | Healthcare | — | |
| “Maintains an 'overweight' rating on the Healthcare sector, indicating a positive investment stance. This sector is among…” | JPMorgan AnalysisJPMorgan | Nifty Healthcare Index | — | |
| “Bullish on the healthcare sector, specifically hospitals, as it is expected to maintain strong earnings growth. The earn…” | Shibani Sircar KurianKotak Mahindra AMC | Nifty Healthcare Index | — | |
| “Bullish on the Indian pharmaceutical market, projecting 8-9% growth in 2025, outpacing the U.S. market. Favors domestic-…” | CLSA AnalysisCLSA | Nifty Healthcare Index | — | |
| “Bullish on the healthcare theme for long-term investment, recommending representation in portfolios while cautioning aga…” | Suranjana BorthakurMirae Asset Investment Managers | Nifty Healthcare Index | — | |
| “Bullish on the healthcare sector, specifically hospitals, traditional pharma, and CDMOs. Hospitals have a secular demand…” | Rahul ChadhaShikhara Investment | Nifty Healthcare Index | — | |
| “Bullish on the Healthcare sector, which has been holding out and performing better than the market since November. It is…” | Rohit SrivastavaStrike Money Analytics and Indiacharts | Nifty Healthcare Index | — | |
| “Bullish on the Indian healthcare sector for its global competitiveness and significant growth headroom as GDP per capita…” | Aditya KhemkaInCred Asset Management | Nifty Healthcare Index | — | |
| “Bullish on the healthcare sector, both through private equity and listed space, as the Indian economy grows. He notes th…” | Anurag SinghAnsid Capital | Nifty Healthcare Index | — | |
| “PL Capital is overweight on the Healthcare sector, increasing weights in Sun Pharmaceutical Industries and identifying H…” | PL Capital AnalysisPL Capital | Nifty Healthcare Index | — | |
| “Bullish on the Indian healthcare sector, viewing it as the next big go-to sector with potential for exciting young compa…” | Aswath DamodaranNYU | Nifty Healthcare Index | — |
Composition
20 stocks
Member stocks, ranked by today's change — biggest gainers first, biggest losers last.
APOLLOHOSP
Apollo Hospitals Enterprise Ltd. · Healthcare
₹9,200
+5.29%
MAXHEALTH
Max Healthcare Institute Ltd. · Healthcare
₹1,081
+3.88%
KIMS
Krishna Institute of Medical Sciences Ltd. · Healthcare
₹795.6
+3.62%
ABBOTINDIA
Abbott India Ltd. · Healthcare
₹26,525
+3.23%
FORTIS
Fortis Healthcare Ltd. · Healthcare
₹825
+1.87%
TORNTPHARM
Torrent Pharmaceuticals Ltd. · Healthcare
₹4,689.5
+1.70%
GLENMARK
Glenmark Pharmaceuticals Ltd. · Healthcare
₹2,648
+1.51%
MANKIND
Mankind Pharma Ltd. · Healthcare
₹2,665
+1.37%
GLAND
Gland Pharma Ltd. · Healthcare
₹3,331.9
+1.18%
ALKEM
Alkem Laboratories Ltd. · Healthcare
₹5,185
+0.78%
LUPIN
Lupin Ltd. · Healthcare
₹2,014
+0.76%
BIOCON
Biocon Ltd. · Healthcare
₹364.4
+0.21%
DIVISLAB
Divi's Laboratories Ltd. · Healthcare
₹11,180.5
+0.02%
ZYDUSLIFE
Zydus Lifesciences Ltd. · Healthcare
₹1,200
-0.24%
CIPLA
Cipla Ltd. · Healthcare
₹1,415
-0.25%
AUROPHARMA
Aurobindo Pharma Ltd. · Healthcare
₹1,799
-0.37%
LAURUSLABS
Laurus Labs Ltd. · Healthcare
₹2,294.6
-0.49%
DRREDDY
Dr. Reddy's Laboratories Ltd. · Healthcare
₹1,390.2
-0.76%
SUNPHARMA
Sun Pharmaceutical Industries Ltd. · Healthcare
₹1,884.9
-0.79%
IPCALAB
Ipca Laboratories Ltd. · Healthcare
₹1,843.8
-0.87%
Index levels are informational only, not investment advice.
How JSW Steel, Dr Reddy’s, Mankind Pharma are fine-tuning AI investments
Mankind Pharma’s global CFO, Ashutosh Dhawan, highlighted the company’s AI strategy at the ETCFO Annual Conclave, stressing the need to balance immediate productivity gains with long‑term capability building. Dhawan noted that Mankind Pharma is prioritising AI projects that deliver measurable operational efficiencies while also investing in foundational data and compliance systems that may not show instant ROI. This dual approach aims to strengthen future competitiveness without compromising current financial discipline.
Apollo Hospitals Enterprise Ltd up 5.29% on Friday
Apollo Hospitals Enterprise Ltd shares rose 5.29% on Friday. The increase reflects a notable intraday gain for the healthcare company, which may influence investor sentiment and short‑term trading activity.
Max Healthcare Institute rises 3.88% in Friday's session
Global Banking & Finance Review · 2 days ago
Krishna Institute of Medical Sciences (NSE: KIMS) Q2 FY27 Results: Revenue Growth and Margin Trends
Kalkine India · 2 days ago
Max Healthcare, Apollo Hospitals, other healthcare stocks surge over 5% despite volatile market; what’s behind the surge?
Upstox · 3 days ago
Cipla - IndiGo, Tata Motors PV among 10 Nifty stocks facing earnings downgrades
The Economic Times · 3 days ago
Gland Pharma Holders Are Up 93% And Here Is What They Saw
Gland Pharma’s shares have risen about 93% year‑to‑date, reaching roughly ₹3,293 from ₹1,715 at the start of 2026. The rally follows a U.S. FDA approval for a methylprednisolone injectable, which helped lift quarterly revenue to ₹18.34 billion and improve net margin to 15.9%, prompting optimistic fair‑value estimates despite some analysts warning of capacity‑utilisation risks.
Fortis Healthcare rises 2.05% in Thursday's session
Global Banking & Finance Review · 3 days ago
Alkem Labs shares fall 2% as US FDA issues warning letter to its Daman manufacturing facility
Upstox · 4 days ago
Stocks for quick gains: Know target price, stop loss for GAIL, Tata Consumer and Cipla
Cipla shares have rebounded above key moving‑average support, with the RSI at 62.07 indicating growing buying pressure. Choice Broking’s analyst recommends buying at ₹1,417, setting a stop‑loss at ₹1,345 and targeting ₹1,560, which could yield roughly a 10.1% return if the bullish trend continues.
Glenmark Pharma shares rise over 2% as unit files US application for experimental solid-tumour drug
Moneycontrol.com · 5 days ago
LINK PHARMA Share Price Today Up 11%
Gland Pharma shares rose about 80% over the past twelve months, making it one of the top gainers in the BSE Healthcare index. The surge contrasts with broader market trends, as the BSE Healthcare index gained 17.8% while the BSE Sensex fell 3.2% in the same period.
Oyster Renewable Invests INR 372 Crore In 60.9 MW Wind-Solar Hybrid Project For Laurus Labs In Andhra Pradesh
SolarQuarter · 5 days ago
Glenmark shares gain 2% to ₹2,673 after IND filing for first in class pentaspecific cancer antibody ISB 2301
Business Upturn · 5 days ago
Lupin: Nomura raises target price to Rs 2,780, sees nearly 40% upside as valuations turn attractive
Moneycontrol.com · 5 days ago